Improving laboratory facilities for HIV/AIDS research at the New Iberia Research Center
Official title: “Renovation of Building 29 laboratories at the New Iberia Research Center"
Funded at University of Louisiana at Lafayette · NIH-10547926 · Data updated 2026-11-12
The New Iberia Research Center is upgrading its labs to help scientists study HIV/AIDS and other infectious diseases better, which will lead to new vaccines and treatments that can help people living with these conditions.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Louisiana at Lafayette NIH-funded |
| Lab location | 1 site (Lafayette, United States) |
| Project start | September 19, 2022 |
| Project end | August 31, 2026 |
| Funding year | 2022 |
| Award (this year) | $2,000,000 |
| NIH project number | 1C06OD034041-01 |
| Project ID | NIH-10547926 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals affected by HIV/AIDS and those involved in related clinical trials.
✕Less likely to help
Patients who are not affected by infectious diseases or who do not have a connection to HIV/AIDS research may not receive direct benefits from this project.
What this research studies
The New Iberia Research Center (NIRC) is expanding its laboratory facilities to support critical research on HIV/AIDS and other infectious diseases. This renovation will create additional space for research teams, allowing for enhanced studies on vaccine development and antibody distribution. The project includes the removal of hazardous materials and the construction of modern laboratory environments to facilitate advanced research methodologies. By increasing capacity, NIRC aims to attract top researchers and improve the efficiency of ongoing studies.
Why it matters
Potential benefit: If successful, this research could lead to significant advancements in the understanding and treatment of HIV/AIDS and other infectious diseases.
How similar studies have gone: Other research institutions have successfully expanded laboratory facilities to enhance infectious disease research, indicating that this approach is both tested and effective.
Where this research is happening
-
University of Louisiana at Lafayette
Lafayette, United States Active
Researchers
- Principal investigator: Villinger, Francois J — University of Louisiana at Lafayette
- Study coordinator: Villinger, Francois J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.